Business Information
The group's principal activities are the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. The group's principal pharmaceutical products include medicines in the following therapeutic areas: central nervous system, respiratory, anti-virals, anti-bacterials, vaccines, oncology and emesis, metabolic, cardiovascular and urogenital. The group has operational headquarters in philadelphia, and research triangle park, usa, and operations in some 117 countries, with products sold in over 130 countries. The principal research and development facilities are in the UK, the usa, Japan, Italy and Belgium. During the year 2003, the group acquired europharm holdings sa.
|
|
Name |
Title
|
Email
|
| Bob Ingram | Vice Chmn. - Pharmaceuticals | Available | | Christopher Gent | Chmn. | Available | | Andrew Witty | Pres. - Pharmaceuticals Europe | Available | | Chris Viehbacher | Pres. - US Pharmaceuticals | Available | | David Pulman | Pres. - Global Manufacturing, Supply | Available
|
|
|
Year |
Sales |
Net Income |
| 2006 | 45,500,098 | 8,747,382 | | 2005 | 37,272,528 | 5,740,589 | | 2004 | 39,223,649 | 5,263,471
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
